Chemotherapy is standard care in resected gastric cancer (GC). Despite the evidence that combination chemotherapy (CT) increases overall survival (OS) as compared to single agent therapy in metastatic disease, no study proved this benefit in the adjuvant setting. We performed a systematic review and meta-analysis based on trial data on the role of combination over single agent CT as adjuvant treatment of GC.
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials / R. Iacovelli, F. Pietrantonio, C. Maggi, F. de Braud, M. Di Bartolomeo. - In: CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. - ISSN 1879-0461. - 98(2016 Feb), pp. 24-28. [10.1016/j.critrevonc.2015.09.002]
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials
F. PietrantonioSecondo
;C. Maggi;F. de BraudPenultimo
;
2016
Abstract
Chemotherapy is standard care in resected gastric cancer (GC). Despite the evidence that combination chemotherapy (CT) increases overall survival (OS) as compared to single agent therapy in metastatic disease, no study proved this benefit in the adjuvant setting. We performed a systematic review and meta-analysis based on trial data on the role of combination over single agent CT as adjuvant treatment of GC.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1040842815300433-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
960.78 kB
Formato
Adobe PDF
|
960.78 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
